Varicosities of the great saphenous vein Completed Phase 2 Trials for Polidocanol (DB06811)

Also known as: Vein, Varicose / Veins, Varicose / Varicose Veins / Varicose Vein / Varicose veins NOS / Vein varicose / Venous varices / Varicosity

IndicationStatusPhase
DBCOND0025660 (Varicosities of the great saphenous vein)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00928421An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose VeinsTreatment
NCT00442364Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac ShuntTreatment